Semplicini Andrea, Lenzini Livia, Sartori Michelangelo, Papparella Italia, Calò Lorenzo A, Pagnin Elisa, Strapazzon Giacomo, Benna Clara, Costa Rodolfo, Avogaro Angelo, Ceolotto Giulio, Pessina Achille C
Department of Clinical and Experimental Medicine, University of Padova, Italy.
J Hypertens. 2006 Jun;24(6):1115-24. doi: 10.1097/01.hjh.0000226202.80689.8f.
RGS2 (regulators of G-protein signaling) is a negative regulator of Galphaq protein signaling, which mediates the action of several vasoconstrictors. RGS2-deficient mouse line exhibits a hypertensive phenotype and a prolonged response to vasoconstrictors.
To compare RGS2 expression in peripheral blood mononuclear cells (PBMs) and cultured fibroblasts from normotensive subjects and hypertensive patients.
PBMs were isolated from 100 controls and 150 essential hypertensives. Additionally, fibroblasts were isolated from skin biopsy of 11 normotensives and 12 hypertensives and cultured up to the third passage. Quantitative mRNA and protein RGS2 expression were performed by real-time quantitative reverse transcriptase-polymerase chain reaction and by immunoblotting, respectively. Free Ca measurement was performed in monolayers of 24-h serum-deprived cells, using FURA-2 AM. Phosphorylation of the extracellular signal-regulated kinases ERK1/2 was measured by immunoblotting. Polymorphism (C1114G) in the 3' untranslated region of the RGS2 gene was investigated by direct sequencing and real-time polymerase chain reaction (PCR).
RGS2 mRNA expression was significantly lower in PBM and in fibroblasts from hypertensives, in comparison to normotensives. C1114G polymorphism was associated with RGS2 expression, with the lowest values in GG hypertensives. The 1114G allele frequency was increased in hypertensives compared with normotensives. Angiotensin II-stimulated intracellular Ca increase and ERK1/2 phosphorylation were higher in fibroblasts from hypertensive patients compared with control subjects, and in those with the G allele, independently of the blood pressure status. The angiotensin II-stimulated Ca mobilization and ERK1/2 phosphorylation were negatively correlated with RGS2 mRNA expression.
Low expression of RGS2 contributes to increased G-protein-coupled signaling in hypertensive patients. The allele G is associated with low RGS2 expression and blood pressure increase in humans.
RGS2(G蛋白信号调节剂)是Gαq蛋白信号的负调节因子,介导多种血管收缩剂的作用。RGS2基因缺陷小鼠品系表现出高血压表型以及对血管收缩剂的反应延长。
比较正常血压受试者和高血压患者外周血单个核细胞(PBM)及培养的成纤维细胞中RGS2的表达。
从100名对照者和150名原发性高血压患者中分离PBM。此外,从11名正常血压者和12名高血压患者的皮肤活检中分离成纤维细胞,并培养至第三代。分别通过实时定量逆转录-聚合酶链反应和免疫印迹法检测RGS2的定量mRNA和蛋白表达。使用FURA-2 AM在24小时血清饥饿细胞单层中进行游离钙测量。通过免疫印迹法检测细胞外信号调节激酶ERK1/2的磷酸化。通过直接测序和实时聚合酶链反应(PCR)研究RGS2基因3'非翻译区的多态性(C1114G)。
与正常血压者相比,高血压患者的PBM和成纤维细胞中RGS2 mRNA表达显著降低。C1114G多态性与RGS2表达相关,GG型高血压患者的值最低。与正常血压者相比,高血压患者中1114G等位基因频率增加。与对照受试者相比,高血压患者成纤维细胞中血管紧张素II刺激的细胞内钙增加和ERK1/2磷酸化更高,在具有G等位基因的患者中也是如此,与血压状态无关。血管紧张素II刺激的钙动员和ERK1/2磷酸化与RGS2 mRNA表达呈负相关。
RGS2低表达导致高血压患者中G蛋白偶联信号增加。等位基因G与人类RGS2低表达和血压升高有关。